Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel vs Combination Chemotherapy in 2nd-line Advanced NSCLC
NCT00345059Phase 3Terminated
- Sponsor
- National Cancer Institute
- Start
- May 2005
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started May 2005; status: terminated.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00345059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345059.